Skip to main content
Year archive

MorphoSys AG — 2004 filings

All 42 regulatory filings released by MorphoSys AG (MOR) in 2004, sourced directly from the official regulator.

42 Filings
2004 Period
2004 filings (42)
Filing Released Lang
MorphoSys AG: MorphoSys Expands Collaboration With Centocor
M&A Activity
2004-12-23 English
MorphoSys Announces Extension of Strategic Partnership with Schering AG
M&A Activity
2004-12-20 English
MorphoSys AG
Director's Dealing
2004-12-13 German
MorphoSys AG
Director's Dealing
2004-12-13 German
MorphoSys Generated Antibody Approved to Enter Clinical Trials
Regulatory Filings
2004-12-09 English
MorphoSys Reports Q3 2004 Results - Expects to Achieve Profitability in 2005
Earnings Release 9M 2004
2004-10-28 English
Q3 Bericht 2004
Interim / Quarterly Report
2004-10-28 German
Q3 Report 2004
Interim / Quarterly Report
2004-10-28 English
MorphoSys to Present at Rodman & Renshaw Techvest Healthcare Conference
Report Publication Announcement
2004-10-25 English
MorphoSys Presents Pre-clinical Development Results for Internal Cancer Project
Regulatory Filings
2004-10-08 English
MorphoSys Enters Marketing Venture with GeneFrontier in Japan
M&A Activity
2004-09-23 English
MorphoSys Obtains License on Crucell Human Cell Line
Regulatory Filings
2004-09-08 English
MorphoSys Announces Inclusion into TecDAX Index
Regulatory Filings
2004-09-06 English
MorphoSys Announces Change in Management Board
Board/Management Information
2004-09-03 English
Centocor Extends License to MorphoSys Therapeutic Antibody
Regulatory Filings
2004-08-25 English
MorphoSys and Boehringer Ingelheim Start New Antibody Program
M&A Activity
2004-08-16 English
MorphoSys Reports Six Months 2004 Results... (Correction)
Earnings Release H1 2004
2004-07-29 English
MorphoSys Reports Six Months 2004 Results and Raises Revenue Guidance
Earnings Release H1 2004
2004-07-29 English
Q2 Bericht 2004
Interim / Quarterly Report
2004-07-29 German
Q2 Report 2004
Interim / Quarterly Report
2004-07-29 English
MorphoSys and Novoplant Sign Veterinary Medicine Collaboration
M&A Activity
2004-07-14 English
MorphoSys is Granted Patent for CysDisplay(TM) Screening Technology
Regulatory Filings
2004-06-24 English
MorphoSys Awarded for Corporate Governance Excellence
Governance Information
2004-06-18 English
MorphoSys AG : Director's-Dealings-Mitteilung
Director's Dealing
2004-06-01 German
MorphoSys and Novartis Forge Strategic Antibody Alliance
M&A Activity
2004-05-19 English
MorphoSys Appoints New Supervisory Board Member
Board/Management Information
2004-05-12 English
MorphoSys Reports First Quarter 2004 Results
Earnings Release Q1 2004
2004-04-29 English
Q1 Report 2004
Interim / Quarterly Report
2004-04-29 English
Q1 Bericht 2004
Interim / Quarterly Report
2004-04-29 German
MorphoSys Widens Scope of U.S. Patent for HuCAL(R) Technology
Regulatory Filings
2004-04-19 English
MorphoSys Achieves Fourth Milestone in Collaboration with Centocor
Regulatory Filings
2004-04-15 English
Q1 Report 2003
Interim / Quarterly Report
2004-03-24 English
Q2 Bericht 2003
Interim / Quarterly Report
2004-03-24 German
Annual Report 2003
Annual Report
2004-03-24 English
Geschäftsbericht 2003
Annual Report
2004-03-24 German
MorphoSys Obtains Additional U.S. Patents on Antibody Technologies
Regulatory Filings
2004-03-17 English
MorphoSys Enters New Antibody Program With Centocor
Regulatory Filings
2004-03-08 English
MorphoSys AG Reports Financial Results for Fiscal Year 2003
Earnings Release FY 2003
2004-02-26 English
MorphoSys Presents Preliminary Financial Results for 2003
Earnings Release FY 2003
2004-02-10 English
MorphoSys Enters New Antibody Market
Regulatory Filings
2004-02-05 English
GPC Biotech Extends License for MorphoSys HuCAL Antibodies against Cancer Target
Regulatory Filings
2004-01-28 English
MorphoSys to Cross-License Technologies with Bayer
Regulatory Filings
2004-01-13 English